Where does Taiwan Liposome Co., Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Taiwan Liposome Co., Ltd. ranks #11,094 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Taiwan Liposome Co., Ltd. hold?

Taiwan Liposome Co., Ltd. holds 28 US utility patents granted between 2015 and 2025, spanning 6 technology areas.

What is Taiwan Liposome Co., Ltd.'s Innovation Score?

Taiwan Liposome Co., Ltd. has an Innovation Score of 33.9 out of 100 (46th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Taiwan Liposome Co., Ltd. focus on?

Taiwan Liposome Co., Ltd.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 27 patents, ranking #847 of 7,163 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

Is Taiwan Liposome Co., Ltd.'s patent grant rate increasing or decreasing?

Taiwan Liposome Co., Ltd.'s recent grant velocity is +10% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Taiwan Liposome Co., Ltd.'s patents?

Taiwan Liposome Co., Ltd.'s patents average 15.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Taiwan Liposome Co., Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Taiwan Liposome Co., Ltd.

USPTO PatentsView assignee record - 28 granted patents across 6 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Taiwan ranks #11,094 of 49,997 tracked US assignees by granted-patent volume, with 28 patents across 6 technology areas.

#11,094
of 49,997 US assignees by volume: 46th percentile
by Innovation Score (33.9/100): 15.9
avg claims per patent: +10%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R11094 · Foreign Corporation #11,094 · 28 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 28 grants
UPPER-Q #11,094/49,997
PHOTO-FINISH Sunstar Suisse
CPC-NARROW A61K · 6 areas
INNOV-THIN 33.9/100
CLAIMS-RICH 15.9 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-UP +10% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Sunstar Suisse SA (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Taiwan’s 33.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.6 pts (34%) Velocity 4.0 pts (12%) Breadth 8.7 pts (26%) Claim depth 9.6 pts (28%)

Qualcomm Incorporated · highest

85
Farapulse · near

34
Fujirebio · near

34
NuVessl · near

34
Reliance Jio Infocomm · near

34
Taiwan Liposome · this assignee

34
3D Lighting… · lowest

7

What this shows Taiwan's Innovation Score is 33.9/100 (46th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Taiwan?

Each dot is one of Taiwan’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Taiwan’s own 15.9 claims/patent is ABOVE the 12.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Taiwan vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Taiwan's grants concentrate

Taiwan Liposome Co., Ltd. is a focused PatentsView assignee: 6 CPC subclasses with 96.4% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2019 (5 grants) versus a trough of 1 in 2015. By volume, Taiwan sits between Sunstar Suisse SA and Toyo INK Co., Ltd..

Taiwan's three-year grant acceleration

Taiwan Liposome Co., Ltd. shows 6 grants in 2022–2024 against only 10 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Sunstar Suisse

28
Superpedestrian

28
Synaffix B V

28
T RAD

28
TC Lab

28
THE DUN & Bradstr…

28
Touchtype

28
Toyo INK

28
Taiwan Liposome ◀

28

What this shows Taiwan holds 28 patents at rank #11,093, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Taiwan

By rank, the assignees closest to #11,093 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Taiwan's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Taiwan, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Taiwan ranks #847 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (34 here).

Farapulse, Inc. 34 Fujirebio Inc. 34 Reliance Jio Infocomm Limited 34 NuVessl, Inc. 34

Taiwan's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 46th percentile higher than 46% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Taiwan Liposome Co., Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	3.6%
2017	2	7.1%
2018	2	7.1%
2019	5	17.9%
2020	2	7.1%
2021	3	10.7%
2022	1	3.6%
2023	3	10.7%
2024	2	7.1%
2025partial year	7	25.0%

Which technologies does Taiwan Liposome Co., Ltd. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 27

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 23

C07K - Peptides 9

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 1

Y10S - Technical Subjects Covered BY Former Uspc Cross-reference ART Collections [XRACs] AND Digests 1

Y02A - Technologies FOR Adaptation TO Climate Change 1

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Taiwan Liposome Co., Ltd.'s patent record in context - here's where to go next.

Taiwan Liposome Co., Ltd.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 96.4% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #11,094 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Taiwan Liposome Co., Ltd. against Sunstar Suisse SA, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 33.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.